5-methoxy-n,n-diisopropyltryptamine has been researched along with Rhabdomyolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alatrash, G; Majhail, NS; Pile, JC | 1 |
| Kuwahara, T; Makie, T; Mori, M; Nakakura, T; Oda, S; Okamoto, G; Sasakawa, A; Takada, K; Uehira, T; Umemoto, A; Yajima, K; Yamamoto, Y; Yoshino, M | 1 |
2 other study(ies) available for 5-methoxy-n,n-diisopropyltryptamine and Rhabdomyolysis
| Article | Year |
|---|---|
Rhabdomyolysis after ingestion of "foxy," a hallucinogenic tryptamine derivative.
Topics: 5-Methoxytryptamine; Adult; Diagnosis, Differential; Diuretics; Fluid Therapy; Hallucinogens; Humans; Male; Rhabdomyolysis | 2006 |
Problems in three Japanese drug users with Human Immunodeficiency Virus infection.
Topics: 5-Methoxytryptamine; Adult; Amyl Nitrite; Antiretroviral Therapy, Highly Active; Asian People; Drug Interactions; HIV Infections; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neuroleptic Malignant Syndrome; Rhabdomyolysis; Seizures; Substance-Related Disorders | 2008 |